Skip to main content

Featured

Your daily horoscope: May 9, 2025

  IF TODAY IS YOUR BIRTHDAY A change of direction is a must this year as you have reached the end of your current journey and need a new challenge. Make a break with the past and make it one that cannot be reversed. Move forward fast and don’t look back. ARIES (March 21 - April 20): Someone you meet on your travels will catch your eye and maybe your heart as well. If it’s true that opposites attract you could find yourself getting close to someone whose charms are very different to your own – and remarkably the relationship will work. TAURUS (April 21 - May 21): Someone you think of as a friend will say something today that annoys you intensely. It may be the case though that they can see things that you cannot, so be open to what they tell you. They could be doing you a very big favor. GEMINI (May 22 - June 21): If you listen too much to other people’s advice today you could end up facing in several directions at once and ultimately getting nowhere. Pay attention to what friends a...

article

U.S. Drug Tariffs: A Looming Crisis for Global Supply Chains


The U.S. government's decision to impose tariffs on pharmaceutical imports has sent shockwaves through the healthcare industry, raising concerns about potential drug shortages and skyrocketing costs. Industry leaders warn that these tariffs could disrupt critical supply chains, affecting the availability of essential medications and medical devices.

Johnson & Johnson CEO Joaquin Duato has voiced concerns over the impact of these tariffs, advocating for tax incentives instead of trade barriers to support domestic drug manufacturing Warns Tariffs Could Disrupt U.S. Drug Supply Chains](https://www.theglobeandmail.com/investing/markets/stocks/LLY-N/pressreleases/31903548/jj-ceo-jnj-warns-tariffs-could-disrupt-us-drug-supply-chains/). Meanwhile, a recent survey indicates that healthcare executives anticipate significant price hikes, with some predicting an 18% increase in medical equipment costs and a 33% rise in critical device prices.

The American Hospital Association has urged the administration to reconsider these tariffs, emphasizing the reliance of U.S. healthcare providers on international sources for life-saving drugs and supplies. Experts caution that while the tariffs aim to boost domestic production, the transition could take years, leaving patients vulnerable to shortages and inflated prices.

As pharmaceutical companies scramble to adjust their supply chains, the industry faces an uncertain future. Whether these tariffs will achieve their intended goal or exacerbate existing challenges remains to be seen. Policymakers must weigh the long-term consequences carefully to ensure that patient care and affordability are not compromised.

Comments

Popular Posts